🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

COSM COSM

Company Profile ↓
$0.21
-76.13% 1Y
Mkt Cap$8.64M
P/E-0.33
P/B0.47
52W High$1.25
52W Low$0.17
Book Value$0.45
EPS (TTM)$-0.63

Company Overview

COSM (COSM) is a publicly traded company listed on with a market capitalization of $8.64M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 42.9% CAGR over the past five years.

Recent Developments

  • Dec 2025 Revenue of $65.27M (+19.9% YoY); net profit $-19.14M.
  • Trailing 12 Months Year-on-year growth — revenue +19.9%.
  • 5-Year Trend Long-term compounding — revenue CAGR 42.9%.

Growth & Price Performance

Compounded Sales Growth

5 Years:42.87%
1 Year:19.93%

Stock Price Performance

1 Year:-76.13%
6 Months:-54.10%
3 Months:-39.49%
1 Month:-16.42%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 4% of range
$0.17 $1.25
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)46.49 · Neutral
Price Performance
1M-16.42%
3M-39.49%
6M-54.10%
1Y-76.13%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 42.9% over 5 years.

CONS

  • Trading 82.8% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-0.33
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$0.45
Price to Book
0.47
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
42.87%
Profit 5Y
-
Revenue (YoY)
19.93%
Earnings (YoY)
-

Profitability & Returns

ROCE
-61.40%
ROE
-103.91%
ROA
-29.24%
Profit Margin
-29.33%
Op Margin
-25.59%
Gross Margin
12.10%
EPS (Latest Qtr)
$-0.06
EPS (TTM)
$-0.63

Balance Sheet & Liquidity

Debt/Equity
1.08
Quick Ratio
0.85
Current Ratio
1.00
Debt
$19.97M
Total Assets
$62.37M
Current Assets
$38.39M
Working Capital
$116.41K

Ownership

Promoter Holding
-
Chg in Prom Hold
-
FII / Inst Holding
-
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$65.27M
EBITDA
-
Free Cash Flow
$-8.60M
Operating Cash Flow
$-8.45M
Shares Outstanding
41.15M
Gross Margin
12.10%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Apr 2013Jun 2013Sep 2013Mar 2014Jun 2014Sep 2014Mar 2015Jun 2015Sep 2015Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026
Revenue ---781.06K1.23M5.78M---1.14M955.89K1.41M4.12M6.11M9.55M11.97M8.86M8.51M9.68M8.51M9.69M11.93M12.82M14.35M11.62M14.85M13.60M13.07M13.21M12.02M12.35M12.36M12.82M14.58M13.21M12.41M13.71M14.75M17.11M17.93M
Gross Profit ---------87.68K81.71K144.95K363.69K480.10K774.81K610.00K702.33K793.72K626.16K468.99K799.77K1.19M2.35M2.40M1.00M2.04M2.35M1.89M1.85M1.78M957.08K946.83K1.21M1.33M767.25K1.21M2.05M1.16M2.60M1.38M
Operating Income -58.04K493.72K-79.34K707.88K1.07M5.59M-84.28K-109.80K-75.15K-41.02K-86.93K-30.97K-1.98M-796.64K16.45K-149.55K-78.78K41.49K-173.74K-525.89K-116.56K225.56K986.31K1.08M-1.73M-1.38M-914.55K242.25K-74.36K-344.11K-2.65M-2.58M-3.02M-1.84M-2.50M-2.24M-833.14K-2.65M-1.82M-2.18M
Net Income -58.04K--79.83K614.22K928.28K4.75M-108.65K-132.62K-100.39K-69.11K-114.08K-94.61K-2.03M-839.62K-198.17K-3.06M782.39K3.21M-217.17K-1.54M-1.63M-483.31K1.38M757.87K-2.17M-2.38M-1.94M203.35K-1.24M-1.97M-459.86K-981.53K-3.35M-1.87M-2.59M-8.38M-818.10K-2.83M-5.35M-2.81M
Diluted EPS -0.000.000.000.010.040.000.000.000.000.000.00--0.07-0.02-0.240.060.24-0.02-0.12-0.12-0.040.100.06-0.14-0.15-0.11-7.86-23.37-1.93-0.04-0.09-0.27-0.11-0.15-0.45-0.03-0.10-0.17-0.06
R&D Expense ---------------------------------00015.63K74.64K18.34K0

Profit & Loss (Annual)

Figures in USD.

Metric Jul 2010Jul 2011Jul 2012Dec 2012Jul 2013Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue -----902.37K7.64M533.80K6.76M30.01M37.08M39.68M55.41M56.24M50.35M53.38M54.43M65.27M
Gross Profit ------7.64M48.99K601.04K1.96M2.41M3.66M8.06M8.33M5.96M4.35M4.31M7.90M
Operating Income ---330.59K-455-344.54K288.71K7.12M-442.46K-202.51K-4.87M-1.23M-255.81K2.71M-4.53M-7.47M-21.83M-15.54M-16.70M
Net Income -3.79M-169.25K-330.59K-455-344.54K246.59K6.04M-6.69M-601.00K-6.21M-9.06M-3.30M820.79K-7.96M-13.83M-18.54M-16.18M-19.14M
Diluted EPS ---0.00-0.000.05-0.0580,741.00-0.49-0.68-0.250.06-23.74-33.16-2.15-1.17-0.63
R&D Expense ---------------164.86K533.29K519.36K

Balance Sheet (Annual)

Figures in USD.

Metric Jul 2009Jul 2010Jul 2011Dec 2011Jul 2012Dec 2012Jul 2013Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Jan 2018Dec 2018Dec 2019Jan 2020Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets ----40-18.84K867.05K7.23M657.62K3.12M10.68M-20.69M23.88M-43.84M-68.04M66.01M54.31M65.48M
Current Assets ------------------56.37M36.61M25.46M38.39M
Cash & Equivalents --15.24K-40-18.84K864.49K446.60K198.05K716.59K782.85K-864.34K38.54K-628.39K-20.75M3.83M315.11K715.67K
Inventory ------------------3.45M4.79M4.36M5.78M
Receivables ------------------23.69M19.76M13.48M19.63M
Total Liabilities ----213.16K1.40K358.67K920.73K1.76M1.91M4.87M13.70M-24.01M30.34M-48.01M-28.38M29.97M29.78M47.05M
Current Liabilities --------1.76M1.91M4.87M13.70M-22.27M28.24M-34.29M-21.75M24.32M25.76M38.27M
Long Term Debt -------------145.50K0-10.77M-2.86M3.04M1.56M5.85M
Total Debt ------------------12.03M12.42M11.82M19.97M
Total Equity -4.60K-17.48K-4.76K-917-213.12K-1.40K-339.83K-53.68K5.47M-1.25M-1.75M-3.03M-3.03M-3.32M-6.46M-6.46M-4.16M-39.66M36.04M24.53M18.42M
Shares Outstanding ------------------10.61M15.98M23.69M41.15M

Cash Flows (Annual)

Figures in USD.

Metric Jul 2012Dec 2012Jul 2013Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -66.06K31-72.94K831.40K6.53M-497.09K-2.13M-8.76M-1.56M-4.79M-11.50M--14.87M-15.64M-7.72M-8.45M
Investing Cash Flow ---18.15K-6.76M-43.95K-144.72K-14.48K-195.77K588.93K-117.74K--21.50K-13.76M-798.27K-2.01M
Financing Cash Flow 50.87K91791.73K2.37K504.12K329.12K2.74M9.29M1.99M3.59M12.46M-35.05M12.69M5.05M14.06M
Capital Expenditure -----21.47K-43.95K-12.82K-55.34K-503.36K--117.74K--383.07K-9.17M-1.27M-152.82K
Free Cash Flow ----6.50M-541.04K-2.14M-8.82M-2.06M--11.62M--15.25M-24.80M-8.98M-8.60M
Net Change in Cash ------------20.16M-16.70M-3.47M3.59M
Share Buybacks ----------200.00K376.86K-100.45K0-

Ratios (Annual)

Figures in %.

Metric Jul 2010Jul 2011Jul 2012Dec 2012Jul 2013Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % ------100.0%9.2%8.9%6.5%6.5%9.2%14.5%14.8%11.8%8.1%7.9%12.1%
Operating Margin % -----32.0%93.2%-82.9%-3.0%-16.2%-3.3%-0.6%4.9%-8.1%-14.8%-40.9%-28.6%-25.6%
Net Margin % -----27.3%79.1%-1,252.9%-8.9%-20.7%-24.4%-8.3%1.5%-14.2%-27.5%-34.7%-29.7%-29.3%
ROE % 21,670.6%3,554.1%155.1%32.4%101.4%-459.3%110.4%536.0%34.3%205.1%273.1%51.1%-19.7%--34.9%-51.4%-66.0%-103.9%
ROCE % ------130.0%35.5%11.6%160.9%77.8%5.9%28.4%--16.1%-52.4%-54.4%-61.4%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for COSM

Google News Fri, 31 Jul 2026

Cosmos Health (NASDAQ: COSM) CEO swaps $70K debt for 349,825 shares - Stock Titan

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxNVnVrWG9kel8ybWludmlfTkxJUzkxNGV1cWNRdS1fY1FZbnFZQTF0RDlWankyakpGQ0NkbUtoNnR1YmJ1N0Jha2U1ZFBkT2xJV0pFbnp6X0lVakZ6aDlfaTJSWWpEVUNYRlVjN21NcWZlY3NzV2xBMXNzUHpWeW9Va3JmNzZzbkozTTF6TU…

Google News Fri, 31 Jul 2026

Insider Stock Purchases: July 31, 2026 - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxOZ054TG9Yb0tYR2thZjV5eDVPQmlmSVdUSUZpUVBoYUg2RGFzSGhZVWduV1BYUWxURjdtRGxhb3BndGltMzhYb1VKcExaMmt1YVFXLXJ3Tml0SE8tRFA3NmhrSzB4RmpiSklvMkNCa200cWpYclN3SFRrZFVxUTlzZw?oc=5" target="_…

Google News hu, 16 Jul 2026

Cosmos Health Share Buyback Surpasses $1 Million, Reaching - GlobeNewswire

<a href="https://news.google.com/rss/articles/CBMijwJBVV95cUxOeDV0ZHk1UVc3RkxLamVBcnMySHZDTlZFZXNvZ3lobGhIb3pDUWNvUVVMa0poMERQS2VNOTY4ZHluLXhOX19iSXFOWGN5Slg0VTNlbC1QSmU5R0JldFN1cWxHVTFLeWVySFhTdlV6NHBFdWp6b18wQU5wNnZvV1lJRFhySGlfNVBpYUV1cD…

Google News ue, 30 Jun 2026

Why Did SOC, HTZ, COSM Stocks Tumble To 52-Week Lows? - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNVlBSWU50YllWZDN2Q08xY3E1bXppMjFFcmR6RklCRlNEazJYWkMwMFdwakk5NjZvVXBKVHhjdmlwWjd3bkZ3ZFNqVkpGZmF0Z1FLbmg2NVJNYlZNV2p3VURBVHpqNUl1VGYxcmpSS3pqZTRjQU9zRjl2ZXJad1R1OVkwb0ttSTdSS2wwUD…

Google News Sun, 15 Feb 2026

Investors Give Cosmos Health Inc. (NASDAQ:COSM) Shares A 27% Hiding - simplywall.st

<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxQVEZuWHRDUDMtX1VyYkFpREpsbzlUWks2UTNnRUhiREY5ZUtYaFI5aDV1NXZBYzVfOGNrX2FnREJxbmJIdGM5UmxSR0JWb2t2VWtXUUd4TkY3dTlUSHJfSTJjRHdYUThReFp6QXNYZ3FxZmExS1VtNG8xUkJVYUtic0ozVXpIbkl5OUVtZm…

Google News hu, 30 Jul 2026

Cosmos Health Inc. (COSM) CFO swaps $60,000 debt for company stock - Stock Titan

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxNZWN3MnNmYzdzdHJLbDlaSERleEdrYXFsSTktclRhcktfTERrRDFXaVpsN2puaVc1bG82OWNISWhzRUlzZVlsMUxJUUlYVXV2MWZVUkplY3I0aVZBWHB4ekpSVmRqVHN6eUFvSG1DUmh1N1cwdFBuTktGVm90c1VvVnowRldaRjh2UFBWVU…

COSM — Frequently Asked Questions

What is the current share price of COSM?

As of 2026-08-05 17:25 PDT, COSM trades at $0.21 on NASDAQ/NYSE. Its 52-week range is $0.17 to $1.25.

What is the market capitalisation of COSM?

COSM has a market capitalisation of $8.64M on NASDAQ/NYSE.

What is the P/E ratio of COSM?

COSM trades at a trailing price-to-earnings (P/E) ratio of -0.33. Its price-to-book (P/B) ratio is 0.47.

What is the return on equity (ROE) of COSM?

COSM has a return on equity (ROE) of -103.91%. Its return on capital employed (ROCE) is -61.40%.

Is COSM a good stock to buy?

This page provides a data-driven analysis of COSM, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space